APA (7th ed.) Citation

Moussa, M. J., Khandelwal, J., Wilson, N. R., Naik, S. A., Subbiah, V., Campbell, M. T., . . . Alhalabi, O. (2024). Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy. Current Oncology, 31(6), 3342. https://doi.org/10.3390/curroncol31060254

Chicago Style (17th ed.) Citation

Moussa, Mohammad Jad, Jaanki Khandelwal, Nathaniel R. Wilson, Sagar A. Naik, Vivek Subbiah, Matthew T. Campbell, Pavlos Msaouel, Parminder Singh, and Omar Alhalabi. "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy." Current Oncology 31, no. 6 (2024): 3342. https://doi.org/10.3390/curroncol31060254.

MLA (9th ed.) Citation

Moussa, Mohammad Jad, et al. "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation: A Molecular-Directed Strategy." Current Oncology, vol. 31, no. 6, 2024, p. 3342, https://doi.org/10.3390/curroncol31060254.